載入中
NASDAQHealthcareMedical - Devices
最新資料
US$106.68
−US$0.02 · -0.02%
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
收盤時
US$106.68
−US$0.02 · -0.02%
盤後
US$108.02
+US$1.34 · +1.26%
10月12日 下午5:09 ET
盤中時間採用ET。市場資料可能有所延遲。
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
日內區間
目前US$106.68
52週區間
目前US$106.68
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 7.47億 USD | 5.92億 USD | 4.93億 USD | 4.11億 USD | 3.23億 USD |
| 銷貨成本 | 2.2億 USD | 1.84億 USD | 1.61億 USD | 1.29億 USD | 1.09億 USD |
| 毛利 | 5.27億 USD | 4.08億 USD | 3.32億 USD | 2.82億 USD | 2.14億 USD |
| 研究與開發 | 8461萬 USD | 1.04億 USD | 6024.4萬 USD | 4661萬 USD | 3867.1萬 USD |
| 銷售、一般及管理費用 | 4.79億 USD | 4.19億 USD | 3.86億 USD | 3.22億 USD | 2.75億 USD |
| 營業費用 | 5.64億 USD | 5.23億 USD | 4.57億 USD | 3.95億 USD | 3.14億 USD |
| 利息收入 | 2152.1萬 USD | 2193.8萬 USD | 615.5萬 USD | 235萬 USD | 11.8萬 USD |
| 利息支出 | 1315.4萬 USD | 1282.1萬 USD | 365萬 USD | 413.8萬 USD | 116.9萬 USD |
| 折舊和攤銷 | 2647.9萬 USD | 2577.7萬 USD | 2214.4萬 USD | 1960.9萬 USD | 1659.4萬 USD |
| 營業利益 | −3681萬 USD | −1.16億 USD | −1.25億 USD | −1.14億 USD | −9994.3萬 USD |
| 淨利 | −4455.1萬 USD | −1.13億 USD | −1.23億 USD | −1.16億 USD | −1.01億 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$174.88
上漲空間 63.93%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1.22億0.01%2.3兆 USD0.03%US$381.57-0.10%
iShares Russell 2000 ETFIWM9200.07萬0.12%787.4億 USD0.19%US$277.9-0.37%
Vanguard Morningstar Small-Cap ETFVB8844.85萬0.05%1853億 USD0.03%US$288.16-0.46%
Vanguard Morningstar Small-Cap Growth ETFVBK5084.83萬0.11%447億 USD0.05%US$340.88-1.12%
Vanguard Extended Market ETFVXF4544.95萬0.05%954億 USD0.05%US$233.52-0.63%
iShares Russell 2000 Growth ETFIWO3262.79萬0.23%139.17億 USD0.24%US$353.71-0.86%
Vanguard Russell 2000 ETFVTWO2264.51萬0.12%180億 USD0.06%US$112.27-0.35%
Schwab U.S. Small-Cap ETFSCHA1853.08萬0.08%218.24億 USD0.03%US$32.66-0.40%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Growth ETFVBKVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
